Table 4 Axillary treatment in the BCS group
From: Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
Axillary treatment | SLND | ALND |
|---|---|---|
N (%) | 15 (10.2%) | 57 (38.7) |
From: Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
Axillary treatment | SLND | ALND |
|---|---|---|
N (%) | 15 (10.2%) | 57 (38.7) |